The PE Ratio as of September 2024 (TTM) for Neurocrine Biosciences, Inc. (NBIX) is 36.20

According to Neurocrine Biosciences, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is 36.20. This represents a change of -24.06% compared to the average of 47.67 of the last 4 quarters.

Neurocrine Biosciences, Inc. (NBIX) Historical PE Ratio (quarterly & annually)

How has NBIX PE Ratio performed in the past?

The mean historical PE Ratio of Neurocrine Biosciences, Inc. over the last ten years is 67.34. The current 36.20 PE Ratio has changed 5.28% with respect to the historical average. Over the past ten years (40 quarters), NBIX's PE Ratio was at its highest in in the December 2017 quarter at 249.47. The PE Ratio was at its lowest in in the March 2015 quarter at -669.18.

Neurocrine Biosciences, Inc. (NBIX) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Neurocrine Biosciences, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Neurocrine Biosciences, Inc. (NBIX) Average PE Ratio

How has NBIX PE Ratio performed in the past?

The current PE Ratio of Neurocrine Biosciences, Inc. (NBIX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Neurocrine Biosciences, Inc. (NBIX) PE Ratio vs. Peers

How is NBIX’s PE Ratio compared to its peers?

Neurocrine Biosciences, Inc.’s PE Ratio is greater than Amphastar Pharmaceuticals, Inc. (13.33), greater than Collegium Pharmaceutical, Inc. (12.07), less than Ironwood Pharmaceuticals, Inc. (77.85), less than ANI Pharmaceuticals, Inc. (43.28), greater than Deciphera Pharmaceuticals, Inc. (-11.74), greater than Alkermes plc (15.66), greater than Avadel Pharmaceuticals plc (-13.12), greater than Intra-Cellular Therapies, Inc. (-90.48), less than Dynavax Technologies Corporation (84.07), greater than Pacira BioSciences, Inc. (10.06), greater than Eagle Pharmaceuticals, Inc. (5.10), greater than Prestige Consumer Healthcare Inc. (18.08), greater than Evotec SE (-3.15), less than Supernus Pharmaceuticals, Inc. (355.12),

Build a custom stock screener for Neurocrine Biosciences, Inc. (NBIX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Neurocrine Biosciences, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Neurocrine Biosciences, Inc. (NBIX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Neurocrine Biosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.